Swiss National Bank Has $7.13 Million Stock Holdings in National Health Investors, Inc. (NYSE:NHI)

Swiss National Bank trimmed its stake in shares of National Health Investors, Inc. (NYSE:NHI) by 0.9% in the third quarter, Holdings Channel.com reports. The firm owned 84,820 shares of the real estate investment trust’s stock after selling 800 shares during the quarter. Swiss National Bank’s holdings in National Health Investors were worth $7,130,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the stock. Assetmark Inc. increased its position in National Health Investors by 27.8% during the 3rd quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock worth $54,000 after purchasing an additional 141 shares in the last quarter. Arizona State Retirement System grew its holdings in National Health Investors by 1.9% during the 2nd quarter. Arizona State Retirement System now owns 12,152 shares of the real estate investment trust’s stock worth $823,000 after acquiring an additional 222 shares during the last quarter. Covestor Ltd grew its holdings in National Health Investors by 2,700.0% during the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 405 shares during the last quarter. Van ECK Associates Corp grew its holdings in National Health Investors by 6.9% during the 2nd quarter. Van ECK Associates Corp now owns 6,404 shares of the real estate investment trust’s stock worth $434,000 after acquiring an additional 416 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new stake in National Health Investors during the 2nd quarter worth approximately $36,000. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Stock Down 0.9 %

Shares of NYSE NHI opened at $77.00 on Tuesday. The firm has a market cap of $3.50 billion, a PE ratio of 26.46, a P/E/G ratio of 5.19 and a beta of 1.05. National Health Investors, Inc. has a 12-month low of $51.59 and a 12-month high of $86.13. The company’s fifty day simple moving average is $79.32 and its 200 day simple moving average is $74.57. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92.

National Health Investors (NYSE:NHI) last issued its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). The company had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm’s revenue was up 1.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.08 earnings per share. As a group, sell-side analysts forecast that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 4.68%. National Health Investors’s payout ratio is 123.71%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Bank of America started coverage on shares of National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price on the stock. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and upped their price objective for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Truist Financial upped their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.